Stay updated on Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial

Sign up to get notified when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-20T04:51:16.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The revision label in the site footer changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T07:57:56.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page instead of the study details, indicating the record is temporarily inaccessible. This change reflects an access issue rather than updated trial information.
    Difference
    17%
    Check dated 2026-09-22T02:52:54.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The study locations list was updated to 13 sites, removing one previously listed location and reducing the total from 14 to 13.
    Difference
    0.5%
    Check dated 2026-09-15T01:17:42.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-31T23:31:06.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.5, replacing the previous v3.6.4. This reflects a newer site deployment while the visible content remains the same.
    Difference
    0.1%
    Check dated 2026-08-10T12:57:37.000Z thumbnail image

Stay in the know with updates to Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.